These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 83307)

  • 21. Isolation of a tumor-associated transplantation antigen (TATA) from an SV40-induced sarcoma. Resemblance to the TATA of chemically induced neoplasms.
    DuBois GC; Appella E; Law LW
    Int J Cancer; 1984 Oct; 34(4):561-6. PubMed ID: 6208155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virus-induced cellular immunity to simian virus 40 tumor-specific surface antigen(s) in adult LVG:LAK hamsters.
    Weppner WA; Coggin JH
    J Natl Cancer Inst; 1980 Apr; 64(4):757-63. PubMed ID: 6245298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
    Law LW
    Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some biologic and biochemical properties of soluble tumor antigens.
    Law LW; Appella E; Henriksen O; Rogers M
    Ann N Y Acad Sci; 1976; 276():11-25. PubMed ID: 194514
    [No Abstract]   [Full Text] [Related]  

  • 25. Cells from chemically induced mouse sarcomas retain tumor-specific transplantation antigenicity during prolonged passage in vitro.
    Walker R; Hellström I; Hellström KE
    Int J Cancer; 1980 Mar; 25(3):345-8. PubMed ID: 7390657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VII. Induction of SV40 TrAg in nonpermissive mouse cells by early viable SV40 deletion (o.54/0.59) mutants.
    Tevethia SS; Flyer DC; Tevethia MJ; Topp WC
    Virology; 1980 Dec; 107(2):488-96. PubMed ID: 6256944
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of immune responses to spontaneous hamster lymphomas.
    Vasa-Thomas KA; Ambrose KR; Bellomy BB; Coggin JH
    J Natl Cancer Inst; 1977 May; 58(5):1287-93. PubMed ID: 67210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of simian virus 40-induced mouse and hamster tumor-specific transplantation antigens.
    Coggin JH
    J Natl Cancer Inst; 1979 Oct; 63(4):1029-34. PubMed ID: 225500
    [No Abstract]   [Full Text] [Related]  

  • 29. Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas.
    Hellström KE; Hellström I; Brown JP
    Int J Cancer; 1978 Mar; 21(3):317-22. PubMed ID: 75855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SV40 T antigen: partial purification and properties.
    Livingston DM; Henderson IC; Hudson J
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 1():283-9. PubMed ID: 169071
    [No Abstract]   [Full Text] [Related]  

  • 31. Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay.
    Paranjpe MS; Boone CW
    J Natl Cancer Inst; 1972 Feb; 48(2):563-6. PubMed ID: 4347042
    [No Abstract]   [Full Text] [Related]  

  • 32. Properties of simian virus 40 small t antigen overproduced in bacteria.
    Thummel CS; Burgess TL; Tjian R
    J Virol; 1981 Feb; 37(2):683-97. PubMed ID: 6261013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification of simian virus 40 and JC T-antigens from transformed cells.
    Cikes M; Beth E; Guignard N; Walker DL; Padgett BL; Giraldo G
    J Natl Cancer Inst; 1977 Sep; 59(3):889-94. PubMed ID: 197246
    [No Abstract]   [Full Text] [Related]  

  • 34. Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma.
    De Leo AB; Becker M; Lu L; Law LW
    Cancer Res; 1993 Apr; 53(7):1602-7. PubMed ID: 7680955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride.
    Coggin JH; Gillis LD; Payne WJ
    J Natl Cancer Inst; 1984 Apr; 72(4):853-62. PubMed ID: 6323810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). I. Specificity of immunoprotection and effect of enzyme treatment on TSTA activity.
    Ansel S; Huet C; Tournier P
    Int J Cancer; 1977 Jul; 20(1):51-60. PubMed ID: 71274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of mice from malignant tumor implants by enucleated tumor cells.
    Sethi KK; Brandis H
    J Natl Cancer Inst; 1974 Oct; 53(4):1175-6. PubMed ID: 4372368
    [No Abstract]   [Full Text] [Related]  

  • 38. Tumor rejection and immunotherapy studies with simian virus 40-induced tumors.
    Blakeslee JR; von Muenchhausen W; Cox HR
    J Med; 1973; 4(4):233-47. PubMed ID: 4358481
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of simian virus 40-specific tumour rejection by the Ad2+ND2 hybrid virus.
    Jay G; Jay FT; Chang C; Levine AS; Friedman RM
    J Gen Virol; 1979 Aug; 44(2):287-96. PubMed ID: 230283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants?
    Klein G; Klein E
    Int J Cancer; 1975 Jun; 15(6):879-87. PubMed ID: 50291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.